DR. DAVID MARK KING M.D. NPI 1417049396

NPI Details

DR. David Mark King, M.D. is a medical oncology internal medicine in Fridley, MN with 33 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. David Mark King, M.D. NPI is 1417049396. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF COLORADO SCHOOL OF MEDICINE, DENVER
Graduation Year:1993

The provider's business location address is:

480 OSBORNE RD NE
SUITE 220
FRIDLEY, MN
ZIP 55432-281
Phone: (763) 786-1620
Fax: (763) 780-3099

The NPI 1417049396 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Unclassified drugs (HCPCS:J3490)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Blood creatinine level (HCPCS:82565)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Folic acid level, serum (HCPCS:82746)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)

The enumeration date for this NPI number is 9/29/2006 and was last updated on 2/21/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.